Onconic Therapeutics Unveils Pancreatic Cancer Trial Data at ASCO, Patient Survives Over 40 Months - FirstWord Pharma

Onconic Therapeutics Unveils Pancreatic Cancer Trial Data at ASCO, Patient Survives Over 40 Months  FirstWord PharmaPancreatic Cancer Breakthrough: New Daily Pill Doubles Survival Time For Advanced Patients  NDTVA new pill can double survival time for deadliest cancer: An expert explains why this is a gamechanger  The Indian ExpressNewspaper headlines: Cancer pill's 'precious gift of time' and 'I Dua'  BBCBreakthrough drug nearly doubles survival with advanced pancreatic cancer – an oncologist explains how daraxonrasib overcame an ‘undruggable’ disease  The Conversation